h
Let’s Work Together
[email protected]

Meet Arrosa, the perfect theme to elevate your online presentation with.

Search here!

Articles of Regenerative medicine

J Tissue Viability. 2021 May;30(2):183-189. Cutaneous autoimmune and inflammatory diseases are a major burden of global disease and many lack effective treatments that can derive in different dermatoses like atopic dermatitis. Despite the increase prevalence and the high health-care costs worldwide, the heterogeniety and multifactoriality of these diseases mean that effective treatment options are scarce.

  • Author:
  • Eduardo Anitua
  • Gorka Orive
  • Alfonso L Sabater
  • Hazem M Mousa
  • Xavier Quinones
  • Felipe Valenzuela
  • Ronald Mauricio Sanchez Avila
  • Jesús Merayo
  • Victor L Perez

Int Ophthalmol. 2021 Jul;41(7):2347-2358. To evaluate the safety and efficacy of the surgical use of autologous plasma rich in growth factors fibrin membrane (mPRGF) in improving corneal wound healing and regeneration in a variety of complex ocular surface defects.

  • Author:
  • Ruzafa N
  • Pereiro X
  • Fonollosa A
  • Araiz J
  • Acera A
  • Vecino E.

Front Pharmacol. 2021 Mar 9;12:606275. Plasma rich in growth factors (PRGF) is a subtype of platelet-rich plasma (PRP) that stimulates tissue regeneration and may promote neuronal survival. It has been employed in ophthalmology to achieve tissue repair in some retinal pathologies, although how PRGF acts in the retina is still poorly understood. As a part of the central nervous system, the retina has limited capacity for repair capacity following damage, and retinal insult can provoke the death of retinal ganglion cells (RGCs), potentially producing irreversible blindness. RGCs are in close contact with glial cells, such as Müller cells, that help maintain homeostasis in the retina.

  • Author:
  • Eduardo Anitua
  • María de la Fuente
  • Francisco Muruzábal
  • Jesús Merayo-Lloves

Eur J Ophthalmol. 2021 Mar;31(2):354-360. The purpose of this study was to analyze the biological content and activity of freeze-dried plasma rich in growth factors eye drops after their storage at 4°C and at room temperature for 3 months with respect to fresh samples (time 0)

  • Author:
  • Ruzafa N
  • Pereiro X
  • Fonollosa A
  • Araiz J
  • Acera A
  • Vecino E.

Front Pharmacol. 2021 Feb 26;12:606232. Plasma rich in growth factors (PRGF) is a subtype of platelet-rich plasma that has being employed in the clinic due to its capacity to accelerate tissue regeneration. Autologous PRGF has been used in ophthalmology to repair a range of retinal pathologies with some efficiency. In the present study, we have explored the role of PRGF and its effect on microglial motility, as well as its possible pro-inflammatory effects. Organotypic cultures from adult pig retinas were used to test the effect of the PRGF obtained from human as well as pig blood. Microglial migration, as well as gliosis, proliferation and the survival of retinal ganglion cells (RGCs) were analyzed by immunohistochemistry.

  • Author:
  • Eduardo Anitua
  • Ronald M Sanchez-Avila
  • Edmar E Uribe-Badillo
  • Javier Fernández-Vega Sanz
  • Francisco Muruzabal
  • Nancy Jurado
  • Belén Alfonso-Bartolozzi
  • Jose F Alfonso
  • Begoña Baamonde
  • Jesus Merayo-Lloves

Medicine (Baltimore). 2021 Jan 22;100(3):e24139. To evaluate the efficacy and safety of plasma rich in growth factors (PRGF) in photorefractive keratectomy (PRK) versus Mitomycin C (MMC).This is a comparative, longitudinal and retrospective case-control study (MMC vs PRGF), in patients with a spherical correction from -0.25 to -8.00 D and cylinder correction from -0.25 to -3.00

  • Author:
  • Eduardo Anitua
  • Sabino Padilla
  • Mikel Sánchez
  • Victor Vaquerizo
  • Gerard A Malanga
  • Nicolás Fiz
  • Juan Azofra
  • Christopher J Rogers
  • Gonzalo Samitier
  • Steven Sampson
  • Roberto Seijas
  • Ricardo Elorriaga
  • Jack Taunton
  • Frank Boehm
  • Roberto Prado
  • Ramón Cugat

Int J Mol Sci. 2021 Jan 15;22(2):824. Achilles tendon ruptures are very common tendon ruptures and their incidence is increasing in modern society, resulting in work incapacity and months off sport, which generate a need for accelerated and successful therapeutic repair strategy. Platelet-rich plasma (PRP) is emerging as adjuvant human blood-derived constructs to assist Achilles tendon rupture treatment